Live News EQUITY M impact Jun 26, 2026, 01:00 PM UTC

INCY Presents VGA039 Data

INCY Star Therapeutics is presenting complete data from a Phase 1/2 multidose study of VGA039 in Von Willebrand Disease at the ISTH 2026 Congress

SQUAWKNEWS Updated Jun 26, 2026, 01:00 PM UTC

INCY Star Therapeutics to Present Complete Data from Phase 1/2 Multidose Study of VGA039 in Von Willebrand Disease at ISTH 2026 Congress